(University of Illinois at Urbana-Champaign) Women undergoing chemotherapy for breast cancer have long complained of lingering cognitive impairments after treatment. These effects are referred to as 'chemobrain,' a feeling of mental fogginess. A new study from the University of Illinois reports long-lasting cognitive impairments in mice when they are administered a chemotherapy regimen used to treat breast cancer in humans.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2bMoso5
No comments:
Post a Comment